Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer.
Saved in:
| Title: | Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer. |
|---|---|
| Authors: | Quenel-Tueux, Nathalie (AUTHOR), Debled, Marc (AUTHOR), Rudewicz, Justine (AUTHOR), MacGrogan, Gaetan (AUTHOR), Pulido, Marina (AUTHOR), Mauriac, Louis (AUTHOR), Dalenc, Florence (AUTHOR), Bachelot, Thomas (AUTHOR), Lortal, Barbara (AUTHOR), Breton-Callu, Christelle (AUTHOR), Madranges, Nicolas (AUTHOR), de Lara, Christine Tunon (AUTHOR), Fournier, Marion (AUTHOR), Bonnefoi, Hervé (AUTHOR), Soueidan, Hayssam (AUTHOR), Nikolski, Macha (AUTHOR), Gros, Audrey (AUTHOR), Daly, Catherine (AUTHOR), Wood, Henry (AUTHOR), Rabbitts, Pamela (AUTHOR) |
| Source: | British Journal of Cancer. 8/11/2015, Vol. 113 Issue 4, p585-594. 10p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00070920 |
|---|---|
| DOI: | 10.1038/bjc.2015.247 |
